中药复方治疗缺血性脑卒中研究进展

doi:10.19803/j.1672-8629.20240654

摘要/Abstract

摘要： 目的综述中药复方在治疗缺血性脑卒中的相关研究,为开展更多中药复方治疗缺血性脑卒中临床与实验研究提供参考。方法通过检索从建库至2024年10月20日中国知网、PubMed数据库,对治疗缺血性脑卒中的相关中药复方进行归纳和分析。结果临床表明补阳还五汤、星蒌承气汤、桃红四物汤等中药复方在临床上治疗缺血性脑卒中有较好疗效。结论中药复方在治疗缺血性脑卒中方面具有一定的优势,但研究相对薄弱、临床研究和大规模试验方面存在不足,缺乏多样本、高质量的临床试验,需加大研究力度。

关键词: 中药复方, 缺血性脑卒中, 补阳还五汤, 星蒌承气汤, 桃红四物汤, 灯盏生脉胶囊, 血府逐瘀汤

Abstract: Objective To examine findings related to the applications of TCM compound formulae in the management of ischemic stroke, and to offer data for subsequent clinical and experimental investigations. Methods By searching China Knowledge Network and PubMed for articles published from the inception to October 20, 2024, TCM compound formulae were summarized and evaluated. Results Clinical investigations indicated that TCM compound formulae, including Buyang Huanwu Tang, Xinglou Chengqi Tang, and Taohong Siwu Tang, exhibited substantial therapeutic efficacy in patients with ischemic stroke. Conclusion TCM compound formulae possess considerable benefits in the management of ischemic stroke. However, investigations are comparatively limited, and there is a lack of clinical studies and large-scale trials. Multi-sample and high-quality clinical studies are lacking.

Key words: TCM Compound Formulae, Ischemic Stroke, Buyang Huanwu Tang, Xinglou Chengqi Tang, Taohong Siwu Decoction, Dengzhan Shengmai Capsules, Xue Fu Zhu Yu Tang

中图分类号:

R994.11
R743

刘文杰, 高圆圆, 白雪. 中药复方治疗缺血性脑卒中研究进展[J]. 中国药物警戒, 2024, 21(12): 1382-1387.

LIU Wenjie, GAO Yuanyuan, BAI Xue. Advancements in Treating Ischemic Stroke with Chinese Medicine Compounds Formulae[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1382-1387.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240654

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I12/1382

参考文献

[1] TANG CH, GUO L, LI X, et al.Interpretation of the 2022 Global Stroke Data Report[J]. Journal of Diagnostics Concepts & Practice(诊断学理论与实践), 2023, 22(3): 238-246.
[2] JIANG C, WANG T, LI M, et al.Clinical Efficacy of Naomaili Granules in the Treatment of Acute Cerebral Infarction with Unilateral Visual Field Defect as the Initial Symptom[J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease(中西医结合心脑血管病杂志), 2023, 21(4): 735-738.
[3] WANG LD, PENG B, ZHANG HQ, et al.Summary of the 2020 Chinese Stroke Prevention and Treatment Report[J]. Chinese Journal of Cerebrovascular Diseases(中国脑血管病杂志), 2022, 19(2): 136-144.
[4] LI L, LIU J, CHEN S, et al.Segmentation of Acute Ischemic Stroke Lesions Based on Deep Feature Fusion[J]. Information Fusion, 2023, 114: 102724.
[5] PALAIODIMOU L, TSIVGOULIS G.A New Standard for Thrombolysis in Acute Ischaemic Stroke[J]. The Lancet. Neurology, 2024, 23(11): 1064-1065.
[6] LIU T, LI X, ZHOU X, et al. PI3K/AKT Signaling and Neuroprotection in Ischemic Stroke: Molecular Mechanisms and Therapeutic Perspectives[J/OL]. Neural regeneration research, (2024-10-22)[2024-10-30]. https://doi:10.4103/NRR.NRR-D-24-00568.
[7] TUO Q Z, LEI P.Ferroptosis in Ischemic Stroke: Animal Models and mechanisms[J]. Zoological Research, 2024, 45(6): 1235-1248.
[8] HE YY.Research on the Traditional Chinese Medicine Usage Rules of Chief Physician Liu Guoan in the Treatment of Stroke[D]. Gansu: Gansu University of Traditional Chinese Medicine, 2023.
[9] CHENG Y, GAO WB, LI P, et al.“Stroke triad”, Jinkui Yaolue[J]. Beijing University of Chinese Medicine(北京中医药大学学报), 2023, 46(10): 1361-1366.
[10] LIU JJ, CAO LY, XU JD, et al.Discussion on Blood-Arthralgia Disease Transmitting Asthenia from Taiyin Apoplexy Theory[J]. Chinese Journal of Traditional Chinese Medicine(中华中医药杂志), 2021, 36(8): 4504-4507.
[11] ZHAO X, SHU M.Research Progress in Treatment of Ischemic Stroke with Traditional Chinese Medicine[J]. Medical Review(医学综述), 2021, 27(22): 4548-4552.
[12] ZHU MLM,CHEN K, ZHONG ZY, et al.Research Progress on the Combination of Traditional Chinese and Western Medicine for Staged Differentiation and Treatment of Ischemic Stroke[J]. Western Journal of Traditional Chinese Medicine(西部中医药), 2022, 35(7): 135-140.
[13] SU TR, MA CJ.Research Progress on the Treatment of Stroke with Dihuang Yinzi[J]. Journal of Practical Traditional Chinese Internal Medicine(实用中医内科杂志), 2021, 35(6): 50-52.
[14] WANG XY, MENG WR, XU XY, et al.Effect and Mechanism of Rehmannia Glutinosa Decoction on Angiogenesis in Patients with Ischemic Stroke[J]. Journal of Binzhou Medical College(滨州医学院学报), 2023, 46(4): 246-252, 258.
[15] WEI ZH, LIUFX, PAN XL, et al.The Mechanism of Action of Rehmannia Glutinosa Combined with Mesenchymal Stem Cells in the Treatment of Ischemic Stroke[J]. Chinese Journal of Tissue Engineering Research(中国组织工程研究), 2023, 27(19): 3070-3076.
[16] WANG X, YE L, SUN W, et al.Effect of Dihuang Yinzi on Inflammatory Response in Cerebral Ischemia-Reperfusion Model Rats by Regulating Gut Microbiota[J]. BioMed Research International, 2022, 2022: 3768880.
[17] HE CM, FANG BJ, JIANG C, et al.Research Progress on Traditional Chinese Medicine Compound Therapy for Stroke based on Gut Microbiota[J]. Northwest Pharmaceutical Journal(西北药学杂志), 2024, 39(4): 220-226.
[18] CAO GZ.Regulatory Effect of Dengzhanshengmai Capsule on Neuroinflammation after Cerebral Ischemia-Reperfusion[D]. Beijing: Chinese Academy of Traditional Chinese Medicine, 2023.
[19] JI Y, FAN H, HUA WZ, et al.Multi-Omics and Network Pharmacology Study Reveals the Effects of Dengzhan Shengmai Capsule Against Neuroinflammatory Injury and Thrombosis Induced by Ischemic Stroke[J]. Journal of Ethnopharmacology, 2022, 305: 116092.
[20] XUE YL, YI QL, NING NB, et al.Updated Evidence of Dengzhan Shengmai Capsule Against Ischemic Stroke: A Systematic Review and Meta-Analysis[J]. Journal of Ethnopharmacology, 2022, 283: 114675.
[21] YU CC, LIU LB, CHEN SY, et al.Ancient Chinese Herbal Recipe Huanglian Jie Du Decoction for Ischemic Stroke: An Overview of Current Evidence[J]. Aging and Disease, 2022,13(6): 1733-1744.
[22] ZHENG WX, HE WQ, ZHANG QR, et al.Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury[J]. Inflammation, 2021, 44(5): 2091-2105.
[23] ZHAO Y, LI Z, LU E, et al.Berberine Exerts Neuroprotective Activities against Cerebral Ischemia/Reperfusion Injury through Up-Regulating PPAR-γ to Suppress NF-κB-Mediated Pyroptosis[J]. Brain Research Bulletin, 2021, 177: 22-30.
[24] XU T, WANG X, MA C, et al.Identification of Potential Regulating Effect of Baicalin on NFκB/CCL2/CCR2 Signaling Pathway in Rats with Cerebral Ischemia by Antibody-Based Array and Bioinformatics Analysis[J]. Journal of Ethnopharmacology, 2022, 284: 114773.
[25] YANG RC,TIAN PP, WU CH, et al.Anti-Ischemic Stroke Research of YiQi JieDu Prescription based on Mitochondrial Protection[J].World Traditional Chinese Medicine(世界中医药), 2017, 12(11): 2731-2735.
[26] CAI BJ, LI ST, GAO YH, et al.Study on Protective Mechanism of Yiqi JieDu Prescription based on GPX4 Pathway against Cerebral Ischemic Iron Death[J]. Zhongnan Pharmacy(中南药学), 2024, 22(10): 2551-2559.
[27] YANG JL, CAI BJ, DAI YH, et al.To Explore the Mechanism of YiQi JieDu Formula on Anti-Ischemic Stroke based on the Microbe-Brain-Gut Axis[J]. Chinese Journal of Experimental Formulae(中国实验方剂学杂志), 2024, 30(6): 91-100.
[28] LI L.Clinical Effect of Xuefuzhuyu Decoction Combined with Acupuncture on Ischemic Stroke Patients with Hemiplegia[J]. Health Care in China(中华养生保健), 2023, 41(9): 35-37, 41.
[29] KUANG WF, LI CI, KO CW, et al.To explore the Mechanism of Xuefu Zhuyu Decoction in Treating Coronary Heart Disease and Ischemic Stroke based on Network Pharmacology and Molecular Docking Technology[J]. Global Chinese Medicine(环球中医药), 2024, 17(4): 585-594.
[30] YI T, GAO P, HOU M, et al.The Mechanisms Underlying the Actions of Xuefu Zhuyu Decoction Pretreatment Against Neurological Deficits after Ischemic Stroke in Mice: The mediation of glymphatic function by aquaporin-4 and Its Anchoring Proteins[J]. Frontiers in Pharmacology, 2022, 13: 1053253.
[31] LI L, CHEN YY, ZHAO YQ, et al.Analysis of the Effect of Modified Zhengan Xifeng Decoction Combined with Acupuncture at Sihua Point on the Neurological Function Deficiency and Prognosis of Yin Deficiency Wind Movement Type in Ischemic Stroke[J].Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2023, 41(6): 147-150.
[32] WU J, LIANG YB, WANG DM.Effect of Xingnao Kaiqiao Acupuncture Combined with Zhengan Xifeng Decoction on Neurological and Cognitive Function in Patients with Ischemic Stroke[J]. Jilin Journal of Traditional Chinese Medicine(吉林中医药), 2022, 42(9): 1104-1107.
[33] WANG YM, HU JP, CHENG HJ.The Effects of Two Traditional Chinese Medicine Formulas on Glu Content and NMDA Receptor Subunit NR1 Expression in Brain Tissue of Rats with Cerebral Ischemia-Reperfusion Injury[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy(中国民族民间医药), 2013, 22(12): 33-34.
[34] WU YX, WU TY, YE H, et al.Effects of Pre Treatment with Zhengan Xifeng Decoction on ET-1 Expression, TNF-α Content, and Myeloid Peroxidase Activity in Brain Tissue of Rats with Middle Cerebral Artery Infarction[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2013, 33(7): 530-533.
[35] YU LH, WANG J, CHEN YN, et al.The Effects of three Traditional Chinese Medicine Formulas on the Expression of Intercellular Adhesion Molecule-1 and Vascular Endothelial Growth Factor in Brain Tissue of Rats with Cerebral Ischemia-Reperfusion Injury[J]. Chinese Journal of Gerontology(中国老年学杂志), 2014, 34(6): 1544-1546.
[36] SONG C, FANG X, FANG N, et al.Buyang Huanwu Decoction Suppresses Ischemic Stroke by Suppressing Glycolysis and Cell Apoptosis in Rat Brain Microvascular Endothelial Cells[J]. Brain Research Bulletin, 2024, 215: 111032.
[37] WANG RJ, MA GC, YU S, et al. UPLC-MS Based Metabonomics Revealed the Protective Effects of Buyang Huanwu Decoction on Ischemic Stroke Rats[J]. Toxicology Research, 2024, 13(2): tfae052.
[38] LI YH, HE P, LI WJ, et al.Advances in Studies on Chemical Constituents and Pharmacological Effects of Buyang Huanwu Decoction and Prediction of its Quality Marker (Q-Marker)[J]. Chinese Herbal Medicine(中草药), 2024, 55(13): 4575-4587.
[39] WU FH.Buyang Huanwu Tang Alleviates Oxidative Stress Damage after Cerebral Ischemia-Reperfusion in Rats by Reducing the Use of D1[D]. Guangzhou: Guangzhou University of Chinese Medicine, 2022.
[40] LI MC, LI MZ, LIN ZY, et al.Buyang Huanwu Decoction Promotes Neurovascular Remodeling by Modulating Astrocyte and Microglia Polarization in Ischemic Stroke Rats[J]. Ethnopharmacol, 2024, 323: 117620.
[41] HUANG Q, QI J, GAO Z, et al.Chemical Composition and Protective Effect of Cerebrospinal Fluid of Dan-Deng-Tong-Nao Capsules on Brain Microvascular Endothelial Cells Injured by OGD/R[J]. Ethnopharmacol, 2022, 283: 114705.
[42] SHI YY, ZUO LH, ZHOU L, et al.Research on the Mechanism of Action of Dan Deng Tong Nao Capsule in Treating Cerebral Infarction based on“Component Target Pathway”[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2021, 56(3): 195-203.
[43] WANG L.Protective Effect and Mechanism of Dan Deng Tong Nao Soft Capsule on Promoting Angiogenesis in Rats with Cerebral Ischemia-Reperfusion Injury[D]. Anhui: Anhui University of Traditional Chinese Medicine, 2023.
[44] ZHANG FR, LI QQ, WANG JQ, et al.The Effect of Dan Deng Tong Nao Capsule on Gut Microbiota in Rats with Cerebral Ischemia-Reperfusion Injury[J]. Herald of Medicine(医药导报), 2022, 41(8): 1121-1129.
[45] YIN JY, ZHU JF, LI SL, et al.Study on the Effective Components of Naoxintong Capsule and Its Mechanism of Action Based on HPLC-ESI-Q-TOF-MS/MS Combined with Network Pharmacology[J]. Chinese Pharmacists(中国药师), 2022, 25(4): 584-594.
[46] XIAO FY, XU YZ, CAN XY, et al.Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial[J]. Chinese Journal of Integrative Medicine, 2022, 28(12): 1063-1071.
[47] OU YY, HU S, CHANG M, et al.Catecholamines-Based Myocardial Injury after Acute Ischemic Stroke and Effects of Naoxintong Capsule Therapy[J]. Phytomedicine, 2024, 132: 155697.
[48] WANG MY.Effect of NAOXINTONG Capsule on Ischemic Stroke Patients[J]. Henan Medical Research(河南医学研究), 2021, 30(7): 1309-1310.
[49] CHEN JL, ZHANG LR, CHEN YX, et al.The Therapeutic Effect of Xinglou Chengqi Tang on Acute Cerebral Ischemia Complicated with SIRS and Its Impact on Serum TNF-α and D-L Levels[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2018, 36(11): 2729-2731.
[50] LIU HW, WANG YZ, ZOU YH.Current Study on the Mechanism of Xinglou Chengqi Decoction in the Treatment of Acute Ischemic Stroke[J]. Emergency of Chinese medicine(中国中医急症), 2022, 31(7): 1294-1297, 1316.
[51] GAO Q.Study on the Mechanism of Xinglou Chengqi Decoction in Treating Phlegm-Heat Viscera Excess Syndrome of acute Ischemic Stroke[D]. Beijing: Beijing University of Chinese Medicine, 2021.
[52] LI J, ZHANG L, XUE S, et al.Exploration of the Mechanism of Taohong Siwu Decoction for the Treatment of Ischemic Stroke based on CCL2/CCR2 Axis[J]. Frontiers in Pharmacology, 2024, 15: 1428572.
[53] LI JZ, SU JX, CHANG YF, et al.Protective Effect of Tao Hong Si Wu Decoction against Inflammatory Injury Caused by Intestinal Flora Disorders in An Ischemic Stroke Mouse Model[J]. BMC Complementary Medicine and Therapies, 2024, 24(1): 124.
[54] TANG L, LIU Z, JI Z, et al.Promotion of Mature Angiogenesis in Ischemic Stroke by Taohong Siwu Decoction through Glycolysis Activation[J]. Frontiers in Pharmacology, 2024, 15: 1395167.
[55] TANG L, WANG D, CHANG H, et al.Treating Ischemic Stroke by Improving Vascular Structure and Promoting Angiogenesis Using Taohong Siwu Decoction: an Integrative Pharmacology Strategy[J]. Journal of Ethnopharmacology, 2024, 332: 118372.
[56] LI X,WANG P, ZHENG K, et al.The Molecular Mechanism of Xiaoxuming Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology and Molecular Docking[J]. MedComm-Future Medicine, 2023, 2(3): 5575443.
[57] WU ZQ, QIAN SY, SONG CC, et al.Exploring the Effective Mechanism of Xiaoxuming Tang in Treating Ischemic Stroke Based on Network Pharmacology[J]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), 2021, 37(1): 49-58.
[58] LI JM, YANG MQ, CHEN WR.Clinical Effect of Huangqi Chifeng Tang Combined with Dihuang Yin Zi on Repairing Damaged Neurological Function in Patients with Ischemic Stroke during the Recovery Period[J]. World Chinese Medicine(世界中医药), 2019, 14(11): 3000-3004.
[59] XIANG XW.Clinical Study on the Treatment of Mild Cognitive Impairment after Cerebral Infarction with Dihuang Yinzi Combined with Kidney Tonifying, Phlegm Dispelling and Orifice Opening Acupuncture Method[D]. Shandong: Shandong University of Traditional Chinese Medicine, 2020.